Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Amplify Weight Loss Drug & Treatment ETF THNR

Full chart Compare
Set alert

Price alert · THNR

All alert types
25.74 USD -0.72 (-2.73%)

Nov 5, 2026, 12:19 PM EST

25.74 Day range 26.27
23.40 52-week range 27.94
YTD
+2.07%
1 year
+9.49%

Amplify Weight Loss Drug & Treatment ETF

Issuer
Amplify
Asset class
Equity
Expense ratio
0.59%
Assets under management
$6.07M
NAV
26.37
Holdings
20
Inception
2024-05-21
Top 10 weight
66.19%

Top holdings

  1. LLY Eli Lilly & Co 11.76%
  2. NVO Novo Nordisk A/S 8.92%
  3. AMGN Amgen Inc 6.21%
  4. AZN AstraZeneca PLC 5.88%
  5. REGN Regeneron Pharmaceuticals Inc 5.83%
  6. GILD Gilead Sciences Inc 5.82%
  7. ROP.SW Roche Holding AG 5.64%
  8. ABBV AbbVie Inc 5.59%
  9. PFE Pfizer Inc 5.53%
  10. MRK Merck & Co Inc 5.02%
  11. 4519.T Chugai Pharmaceutical Co Ltd 4.96%
  12. 1093.HK CSPC Pharmaceutical Group Ltd 4.57%
  13. 1801.HK Innovent Biologics Inc 4.32%
  14. VKTX Viking Therapeutics Inc 4.20%
  15. ARWR Arrowhead Pharmaceuticals Inc 3.59%
  16. ZEAL.CO Zealand Pharma A/S 3.25%
  17. 128940.KS Hanmi Pharm Co Ltd 2.86%
  18. 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd 2.35%
  19. GPCR Structure Therapeutics Inc 2.05%
  20. KLRA Kailera Therapeutics Inc 1.05%
  21. Cash & Other 0.38%
  22. AGPXX Invesco Government & Agency Portfolio 12/31/2031 0.22%

Sector weights

  • Healthcare 99.55%
  • Financial Services 0.26%
  • Cash & Others 0.19%

Country weights

  • United States 57.22%
  • Denmark 12.08%
  • China 11.03%
  • United Kingdom 5.90%
  • Switzerland 5.73%
  • Japan 5.14%
  • South Korea 2.89%

Updated 2026-11-06